Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-12-22 POYHONEN JOHN Director Grant or award · Stock Option (Right to Buy) +19,500 19,500
2015-12-22 MANHARD KIMBERLY Director Grant or award · Stock Option (Right to Buy) +19,000 19,000
2015-12-22 Johnson Craig A Director Grant or award · Stock Option (Right to Buy) +19,000 19,000
2015-12-22 Rosen Robert President Grant or award · Stock Option (Right to Buy) +250,000 250,000
2015-12-22 Quart Barry D Chief Executive Officer Grant or award · Stock Option (Right to Buy) +250,000 250,000
2015-12-22 Marshall Paul SVP, Technical Operations Grant or award · Stock Option (Right to Buy) +50,000 50,000
2015-12-22 Drazba Brian G. VP, Finance & CFO Grant or award · Stock Option (Right to Buy) +50,000 50,000
2015-10-30 Drazba Brian G. VP, Finance & CFO Other acquisition +714 $9.36 $7K 2,683
2015-10-14 Quart Barry D Chief Executive Officer Exercise or conversion +10,000 $7.20 $72K 80,055
2015-10-14 Quart Barry D Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −10,000 940,694
2015-10-12 Clendeninn Neil James SVP & Chief Medical Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2015-10-12 Clendeninn Neil James SVP & Chief Medical Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2015-09-29 Quart Barry D Chief Executive Officer Exercise or conversion +14,306 $7.20 $103K 70,055
2015-09-29 Quart Barry D Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −14,306 950,694
2015-08-18 Quart Barry D Chief Executive Officer Exercise or conversion +10,000 $7.20 $72K 55,749
2015-08-18 Quart Barry D Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −10,000 965,000
2015-06-20 Quart Barry D Chief Executive Officer Other acquisition +600 600
2015-06-10 TANG KEVIN C Director Purchase +121,212 $24.75 $3.0M 4,867,530
2015-06-02 MANHARD KIMBERLY Director Exercise or conversion +10,500 $8.80 $92K 10,500
2015-06-02 MANHARD KIMBERLY Director Sale −10,500 $23.58 $248K 0

Page 37 of 38 · 746 trades